Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications.

Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98

Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol (2010) 3.30

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92

Magnetic resonance elastography: a review. Clin Anat (2010) 2.54

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology (2011) 1.80

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62

An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol (2012) 1.57

Noninvasive evaluation of NAFLD. Nat Rev Gastroenterol Hepatol (2013) 1.49

Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol (2012) 1.45

Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39

Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol (2011) 1.34

Abdominal magnetic resonance elastography. Top Magn Reson Imaging (2009) 1.26

Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Reson Imaging (2010) 1.23

Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol (2013) 1.20

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology (2011) 1.17

Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatol Int (2011) 1.15

KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2016) 1.15

Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging (2012) 1.13

Review of MR elastography applications and recent developments. J Magn Reson Imaging (2012) 1.12

Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging (2011) 1.10

Automated liver stiffness measurements with magnetic resonance elastography. J Magn Reson Imaging (2012) 1.10

Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J Gastroenterol (2014) 1.06

Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol (2012) 1.06

MR T1ρ as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur Radiol (2012) 1.05

Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol (2014) 1.04

Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol (2008) 1.02

Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study. Can J Gastroenterol (2010) 1.02

KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol (2014) 0.99

Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations. Radiology (2015) 0.95

Experimental evaluation of accelerated T1rho relaxation quantification in human liver using limited spin-lock times. Korean J Radiol (2012) 0.94

Magnetic resonance elastography noninvasively detects in vivo renal medullary fibrosis secondary to swine renal artery stenosis. Invest Radiol (2013) 0.93

Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am (2011) 0.91

Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol (2010) 0.91

Automated liver elasticity calculation for MR elastography. J Magn Reson Imaging (2015) 0.90

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score. Gut Liver (2013) 0.89

Diffusion Weighted MRI for Hepatic Fibrosis: Impact of b-Value. Iran J Radiol (2014) 0.89

Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol (2013) 0.89

Evaluation of liver fibrosis with T1ρ MR imaging. Quant Imaging Med Surg (2014) 0.88

Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol (2014) 0.87

Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T. Biomed Res Int (2015) 0.84

Further exploration of MRI techniques for liver T1rho quantification. Quant Imaging Med Surg (2013) 0.84

Antifibrotic therapies--emerging biomarkers as treatment end points. Nat Rev Gastroenterol Hepatol (2010) 0.83

Magnetic resonance elastography: a general overview of its current and future applications in brain imaging. Neurosurg Rev (2010) 0.83

3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol (2015) 0.82

MRI of diffuse liver disease: characteristics of acute and chronic diseases. Diagn Interv Radiol (2014) 0.81

Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol (2011) 0.81

MR Imaging of activated hepatic stellate cells in liver injured by CCl4 of rats with integrin-targeted ultrasmall superparamagnetic iron oxide. Eur Radiol (2010) 0.81

Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo. J Magn Reson Imaging (2009) 0.81

Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. World J Gastroenterol (2015) 0.81

Liver lobe volumes and the ratios of liver lobe volumes to spleen volume on magnetic resonance imaging for staging liver fibrosis in a minipig model. PLoS One (2013) 0.80

Spatially-resolved hydraulic conductivity estimation via poroelastic magnetic resonance elastography. IEEE Trans Med Imaging (2014) 0.80

Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World J Hepatol (2015) 0.79

Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep (2014) 0.79

Quantitative assessment of the presence and severity of cirrhosis in patients with hepatitis B using right liver lobe volume and spleen size measured at magnetic resonance imaging. PLoS One (2014) 0.79

State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. Eur J Radiol Open (2015) 0.78

Magnetic Resonance Elastography. Curr Med Imaging Rev (2015) 0.78

Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol (2015) 0.78

Concurrent Visualization of Acoustic Radiation Force Displacement and Shear Wave Propagation with 7T MRI. PLoS One (2015) 0.77

Histogram analysis of hepatobiliary phase MR imaging as a quantitative value for liver cirrhosis: preliminary observations. Yonsei Med J (2014) 0.77

MR Elastography of Liver Disease: State of the Art. Appl Radiol (2013) 0.77

Effects of gadoxetic acid on liver elasticity measurement by using magnetic resonance elastography. Magn Reson Imaging (2011) 0.77

Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices. World J Gastroenterol (2015) 0.77

Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. Aliment Pharmacol Ther (2011) 0.76

Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. World J Gastroenterol (2015) 0.75

Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ3 for staging liver fibrosis in rat model. Int J Nanomedicine (2016) 0.75

Application of Single Voxel 1H Magnetic Resonance Spectroscopy in Hepatic Benign and Malignant Lesions. Med Sci Monit (2016) 0.75

Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis C. Hepat Mon (2011) 0.75

Magnetic resonance elastography in a rabbit model of liver fibrosis: a 3-T longitudinal validation for clinical translation. Am J Transl Res (2016) 0.75

MR imaging in liver cirrhosis: classical and new approaches. Insights Imaging (2010) 0.75

Imaging patterns of fatty liver in pediatric patients. Diagn Interv Radiol (2015) 0.75

Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Sci Rep (2017) 0.75

T2 relaxation time is related to liver fibrosis severity. Quant Imaging Med Surg (2016) 0.75

Stable Automated Segmentation of Liver MR Elastography Images for Clinical Stiffness Measurement. Proc SPIE Int Soc Opt Eng (2013) 0.75

Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol (2016) 0.75

The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology (2005) 15.74

Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med (2008) 9.32

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68

Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67

Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol (2007) 5.77

Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med (2013) 5.19

Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00

The Budd-Chiari syndrome. N Engl J Med (2004) 3.95

Acute-on chronic liver failure. J Hepatol (2012) 3.74

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology (2002) 3.50

MR elastography of the liver: preliminary results. Radiology (2006) 3.20

MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol (2009) 2.80

MR elastography of breast cancer: preliminary results. AJR Am J Roentgenol (2002) 2.65

Magnetic resonance elastography of the brain. Neuroimage (2007) 2.59

Splanchnic artery aneurysms. Mayo Clin Proc (2007) 2.55

Magnetic resonance elastography: a review. Clin Anat (2010) 2.54

Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology (2007) 2.36

Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) (2006) 2.34

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30

Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology (2014) 2.27

Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology (2006) 2.25

Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging (2013) 2.22

CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics (2006) 2.21

Mesenteric venous thrombosis. Mayo Clin Proc (2013) 2.09

A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology (2008) 2.02

Metastatic malignant melanoma of the gastrointestinal tract. Mayo Clin Proc (2006) 1.99

Retained Capsule Endoscopy in a Large Tertiary Care Academic Practice and Radiologic Predictors of Retention. Inflamm Bowel Dis (2015) 1.97

Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet (2004) 1.96

Performance standards for therapeutic abdominal paracentesis. Hepatology (2004) 1.93

Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology (2009) 1.90

Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant (2004) 1.87

Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology (2008) 1.87

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl (2007) 1.86

A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83

Transjugular intrahepatic portosystemic shunts: an update. Liver Transpl (2003) 1.83

Hepatocellular carcinoma after the Fontan procedure. N Engl J Med (2013) 1.81

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology (2011) 1.80

Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74

Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography. J Magn Reson Imaging (2011) 1.72

MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol (2008) 1.69

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol (2010) 1.67

Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D. Clin Gastroenterol Hepatol (2006) 1.66

A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology (2008) 1.65

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology (2003) 1.65

Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery (2012) 1.64

Bias observed in time-of-flight shear wave speed measurements using radiation force of a focused ultrasound beam. Ultrasound Med Biol (2011) 1.62

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62

Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62

Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med (2007) 1.61

Crohn Disease: mural attenuation and thickness at contrast-enhanced CT Enterography--correlation with endoscopic and histologic findings of inflammation. Radiology (2006) 1.60

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57

Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54

ACR Appropriateness Criteria® right lower quadrant pain--suspected appendicitis. J Am Coll Radiol (2011) 1.51

Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet (2003) 1.47

Determination of thigh muscle stiffness using magnetic resonance elastography. J Magn Reson Imaging (2006) 1.46

Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity. Dig Dis Sci (2011) 1.43

Mechanical transient-based magnetic resonance elastography. Magn Reson Med (2005) 1.42

Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl (2007) 1.39

Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol (2009) 1.39

Applications of magnetic resonance elastography to healthy and pathologic skeletal muscle. J Magn Reson Imaging (2007) 1.39

Medical and surgical treatment options for polycystic liver disease. Hepatology (2010) 1.39

Clinical profile of autosomal dominant polycystic liver disease. Hepatology (2003) 1.37

Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol (2009) 1.37

New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35

Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2008) 1.35

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology (2013) 1.35

Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force. Radiology (2012) 1.34

Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.33

Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care (2011) 1.33

Quantitative shear wave magnetic resonance elastography: comparison to a dynamic shear material test. Magn Reson Med (2005) 1.32

MR elastography as a method for the assessment of myocardial stiffness: comparison with an established pressure-volume model in a left ventricular model of the heart. Magn Reson Med (2009) 1.30

Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc (2003) 1.30

Magnetic resonance elastography as a method for the assessment of effective myocardial stiffness throughout the cardiac cycle. Magn Reson Med (2010) 1.28

A quality initiative to decrease pathology specimen-labeling errors using radiofrequency identification in a high-volume endoscopy center. Am J Gastroenterol (2009) 1.28

Obscure gastrointestinal bleeding: evaluation with 64-section multiphase CT enterography--initial experience. Radiology (2008) 1.28

Abdominal magnetic resonance elastography. Top Magn Reson Imaging (2009) 1.26

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. Hepatology (2010) 1.25

Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol (2003) 1.24

CT of small-bowel ischemia associated with obstruction in emergency department patients: diagnostic performance evaluation. Radiology (2006) 1.23

Thigh muscle stiffness assessed with magnetic resonance elastography in hyperthyroid patients before and after medical treatment. J Magn Reson Imaging (2007) 1.23

Preoperative assessment of meningioma stiffness using magnetic resonance elastography. J Neurosurg (2012) 1.21

Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus. Am J Gastroenterol (2007) 1.20

Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res (2012) 1.19

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology (2015) 1.18

Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology (2003) 1.18

Noninvasive In vivo assessment of renal tissue elasticity during graded renal ischemia using MR elastography. Invest Radiol (2011) 1.18

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16